Observation On The Curative Effect Of Mongolian Traditional Mannose Therapy On Patients With Acute Myocardial Infarction After Emergency PCI

Objective:To observe the curative effect of Mongolian traditional mannose therapy on reducing complications and improving quality of life in patients with acute myocardial infarction after emergency PCI.Methods:A total of 60 patients who met the diagnostic criteria and inclusion criteria were strictly screened in this study.They were randomly assigned to the control group and the treatment group.30 in each group.Control group::basic medicine of western medicine(aspirin enteric-coated tablets 100mg,clopidogrel bisulfate tablets 75mg or tegrenol tablets 90mg,atorvastatin tablets 20mg or rosuvastatin tablets 10mg),exercise rehabilitation.Treatment group:basic western medicine(aspirin enteric-coated tablets 100mg,clopidogrel bisulfate tablets 75mg or tegrenol tablets 90mg,atorvastatin tablets 20mg or rosuvastatin tablets 10mg),exercise rehabilitation,Mongolian medicine foot bath therapy.The observation time was 6 months.In this study,symptoms before and after treatment,observation indicators,Borg score,Barthel scale,SF-12 scale and SAQ scale were used to evaluate the clinical efficacy.The patients were evaluated before treatment,one month after treatment,three months after treatment,four months after treatment,and six months after treatment.At the same time,the patients,EF value,myocardial enzymes,myocardial markers,BNP,blood and urine routine,liver and kidney function were observed.To study the clinical effect of traditional Mongolian medicine mannose therapy on patients with acute myocardial infarction after emergency PCI.Result:1.According to the collected data results,the total effective rate of the two groups of treatment can be counted,and the total effective rate of the treatment group is 93.3%,while the total effective rate of the control group is 86.7%,and the final result is to meet the statistical difference(P<0.05).2.Borg score:compared with before treatment,the Borg score of patients in the treatment group was significantly reduced(P<0.05)after 1 month of treatment,significantly reduced(P<0.01)after 3 months of treatment,and extremely significantly reduced(P<0.01)after 6 months of treatment;Compared with before treatment,the Borg score of the control group was significantly reduced after 1 month of treatment(P<0.05),3 months after treatment(P<0.01),and very significantly after 6 months of treatment(P<0.01).Compared with the control group,patients in the treatment group had a significantly lower Borg score after 6 months of treatment(P<0.05).3.Barthel scale:compared with before treatment,the Barthel score of patients in the treatment group was significantly improved after 1 month of treatment(P<0.05),significantly improved after 3 months of treatment(P<0.01),and very significantly improved(P<0.01)after 6 months of treatment;Compared with before treatment,the Barthel score of the control group was significantly improved after 1 month of treatment(P<0.05),3 months after treatment(P<0.01),and very significantly improved after 6 months(P<0.01).Compared with the control group,the Barthel score in the treatment group was significantly improved after 6 months of treatment(P<0.05).4.SF-12 scale:compared with before treatment,the SF-12 score of patients in the treatment group was significantly improved after 1 month of treatment(P<0.05),significantly improved after 3 months of treatment(P<0.01),and very significantly improved(P<0.01)after 6 months of treatment.Compared with before treatment,the SF-12 score of the control group was significantly improved after 1 month of treatment(P<0.05),3 months after treatment(P<0.01),and very significantly improved(P<0.01)after 6 months of treatment.Compared with the control group,the SF-12 score in the treatment group was significantly improved after 6 months of treatment(P<0.05).5.SAQ scale:after the evaluation of the treatment group,the data before and after treatment of each item were improved,and the degree of physical activity limitation,angina steady state,angina attack frequency,etc.,all data results were compared,and finally showed statistical significance(P<0.05);The treatment satisfaction and disease awareness were improved in both groups,but the data comparison was not much different and there was no significant significance(P>0.05).The comparison between the two groups concluded that the values of the treatment group in the degree of physical activity limitation,angina steady,angina attack frequency,etc.were much higher than those in the control group,and were statistically significant(P<0.05).There were no significant differences in treatment satisfaction and disease awareness(P>0.05).6.The two groups of patients had good efficacy in precordial discomfort,chest tightness,shortness of breath,palpitations,fatigue and other symptoms,and there were significant differences between the two groups before and after treatment,with statistical significance(P<0.05).There were significant differences between the groups(P<0.05).The symptom improvement in the treatment group was more significant than that in the control group.7.There was no significant difference in the LVEF value before and after treatment between the two groups(P>0.05).Compared with 1 month after treatment,3 months after treatment,and 6 months after treatment,the two groups had statistical significance(P<0.05),indicating that the myocardial enzymes,myocardial markers,BNP and other examinations of the two groups were improved after treatment.The improvement in the treatment group was more significant than that in the control group.8.According to the blood routine,liver function,renal function and other tests before and after treatment of the two groups of patients(P>0.05),except for this urine routine before and after treatment,it was normal before and after treatment.